{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2Febc-care-6ZFtVPLf","width":444,"version":"1.0","type":"rich","title":"Advancing the Care of Patients With High-Risk HR-Positive/HER2-Negative Early Breast Cancer","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/a1e162b5-f84a-4993-a2ab-4f58bd2de612/100399-breast-high-risk-1-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/3204f35c-9c4c-45d4-b3e2-afaef501fd6b\" height=\"200\" width=\"100%\" title=\"Advancing the Care of Patients With High-Risk HR-Positive/HER2-Negative Early Breast Cancer\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen to Manali Bhave, MD, and Erin F. Cobain, MD, discuss their management of patients with HR-positive/HER2-negative early breast cancer including insights on identifying high-risk disease considering clinical/pathological factors and gene expression assays and answering healthcare professional questions on how to personalize adjuvant therapy for these patients."}